U.S. Buys 600,000 Doses of New COVID Treatment Still Awaiting FDA Approval

FRIDAY, Feb. 11, 2022 -- The U.S. government has bought 600,000 doses of a new antibody drug called bebtelovimab that seems able to beat back the Omicron variant, even though the medication has yet to be given the green light by the U.S. Food and...